SCHEMBL16320371

SCHEMBL16320371

Cc1cc(Nc2cc(-c3cccs3)n[nH]2)nc(Nc2ccc(NC(=O)N(S)c3ccc(Cl)c(C(F)(F)F)c3)nc2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 3/20 0.33
MAPK14 Q16539 1/20 0.33
MAPT P10636 7/20 0.33
POLB P06746 2/20 0.33
BTK Q06187 1/20 0.33
RAF1 P04049 2/20 0.33
RXFP1 Q9HBX9 3/20 0.32
TP53 P04637 2/20 0.32
FOXM1 Q08050 1/20 0.32
IGF1R P08069 1/20 0.32
CCNE2 O96020 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
CDK8 P49336 2/20 0.31
CCNC P24863 1/20 0.31
CTSC P53634 1/20 0.31
KDM4E B2RXH2 2/20 0.31
TEK Q02763 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16319831 0.89 BRAF (0.39) BRAFMAPK14MAPTBTKRAF1
SCHEMBL16320149 0.88 BTK (0.36) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320357 0.88 BRAF (0.43) BRAFMAPK14RAF1CDK8CCNC
SCHEMBL16323158 0.88 BRAF (0.36) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320252 0.87 IGF1R (0.35) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16319507 0.87 BRAF (0.35) BRAFMAPK14MAPTPOLBBTK
SCHEMBL16319467 0.86 IGF1R (0.35) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320222 0.85 IGF1R (0.41) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320370 0.85 BRAF (0.37) BRAFMAPK14BTKRAF1CCNE2
SCHEMBL16320438 0.85 IGF1R (0.34) BRAFMAPK14MAPTBTKIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221798-B2 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof Zhejian Hisun Pharmaceutical Co., Ltd. (CN) 2015-12-29 US disclosed
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF MAP4K2, MAP4K1, MAP4K3 BRAF 84/4885MAPK14 114/4885MAPT 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.